Alivus Life Sciences Limited has informed the Exchange regarding allotment of 52200 securities pursuant to ESOP/ESPS at its meeting held on August 01, 2025
ALIVUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Alivus Life Sciences (formerly Glenmark Life Sciences) has allotted 52,200 equity shares with a face value of Rs. 2 each to eligible employees who exercised stock options under the company's Employee Stock Option Scheme, 2021. The allotment was approved by the Nomination and Remuneration Committee at its meeting on August 01, 2025. As a result, the company's paid-up equity share capital has increased from 12,26,29,148 shares (Rs. 24,52,58,296) to 12,26,81,348 shares (Rs. 24,53,62,696). The increase represents a very small addition of about 0.004% to the total share count.
This is a routine ESOP allotment causing negligible dilution to existing shareholders. No material impact expected on stock price or shareholder value.